Patents by Inventor Ajit Dhananjay Jagtap

Ajit Dhananjay Jagtap has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • QUINAZOLINE DERIVATIVES USEFUL AS SELECTIVE HDAC6 INHIBITORS
    Publication number: 20230212129
    Abstract: Provided herein is a compound of Formula (I): or a pharmaceutically acceptable salt thereof, wherein the variables are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I) and methods of using the compounds, e.g., in the treatment of neuropathy-related disorders and fibrotic diseases.
    Type: Application
    Filed: June 8, 2021
    Publication date: July 6, 2023
    Inventors: Chao-Wu Yu, Pei-Yun Hung, Ajit Dhananjay Jagtap, Yi-Hsun Ho, Hsin-Yi Chaing
  • Indolin-2-one derivatives as protein kinase inhibitors
    Patent number: 8946282
    Abstract: A novel class of indoline-2-one derivatives are disclosed. These compounds are protein kinase inhibitors which are useful for treating hyperproliferative diseases such as cancer.
    Type: Grant
    Filed: April 3, 2013
    Date of Patent: February 3, 2015
    Assignee: Annji Pharmaceutical Co., Ltd.
    Inventors: Ji-Wang Chern, Ajit Dhananjay Jagtap, Hsiao-Chun Wang, Grace Shiahuy Chen
  • INDOLIN-2-ONE DERIVATIVES AS PROTEIN KINASE INHIBITORS
    Publication number: 20130281451
    Abstract: A novel class of indoline-2-one derivatives are disclosed. These compounds are protein kinase inhibitors which are useful for treating hyperproliferative diseases such as cancer.
    Type: Application
    Filed: April 3, 2013
    Publication date: October 24, 2013
    Applicant: ANNJI PHARMACEUTICAL CO., LTD.
    Inventors: Ji-Wang Chern, Ajit Dhananjay Jagtap, Hsiao-Chun Wang, Grace Shiahuy Chen